Home Biosimilar Antibodies Immunology & Inflammation Complement System antibody Crovalimab (Anti-Complement C5) For research use only.
Not for use in humans.

Crovalimab (Anti-Complement C5)

Synonyms: SKY59; RO7112689

Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.

Crovalimab (Anti-Complement C5)

Purity & Quality Control

Choose Selective Complement System Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.

Product Details

CAS No. 1917321-26-6
Molecular Weight 145.28
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Crovalimab (Anti-Complement C5) | Crovalimab (Anti-Complement C5) supplier | purchase Crovalimab (Anti-Complement C5) | Crovalimab (Anti-Complement C5) cost | Crovalimab (Anti-Complement C5) manufacturer | order Crovalimab (Anti-Complement C5) | Crovalimab (Anti-Complement C5) distributor